Ocumension Therapeutics Stock

Ocumension Therapeutics Debt 2024

Ocumension Therapeutics Debt

-915.82 CNY

Ticker

1477.HK

ISIN

KYG674111011

WKN

A2P723

In 2024, Ocumension Therapeutics's total debt was -915.82 CNY, a -28.72% change from the -1,284.87 CNY total debt recorded in the previous year.

Ocumension Therapeutics Aktienanalyse

What does Ocumension Therapeutics do?

Ocumension Therapeutics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding Ocumension Therapeutics's Debt Structure

Ocumension Therapeutics's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Ocumension Therapeutics's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Ocumension Therapeutics’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Ocumension Therapeutics’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Ocumension Therapeutics stock

What is the debt of Ocumension Therapeutics this year?

Ocumension Therapeutics has a debt level of -915.82 CNY this year.

What was the debt of Ocumension Therapeutics compared to the previous year?

The debt of Ocumension Therapeutics has increased by -28.72% compared to the previous year dropped.

What are the consequences of high debt for investors in Ocumension Therapeutics?

High debt can pose a risk for investors of Ocumension Therapeutics, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of Ocumension Therapeutics?

Low debt means that Ocumension Therapeutics has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from Ocumension Therapeutics affect the company?

An increase in debt of Ocumension Therapeutics can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of Ocumension Therapeutics affect the company?

A reduction in debt of Ocumension Therapeutics can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of Ocumension Therapeutics?

Some factors that can influence the debt of Ocumension Therapeutics include investments, acquisitions, operating costs, and revenue development.

Why are the debts of Ocumension Therapeutics so important for investors?

The debts of Ocumension Therapeutics are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can Ocumension Therapeutics take to change the debt?

To change the debt, Ocumension Therapeutics can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does Ocumension Therapeutics pay?

Over the past 12 months, Ocumension Therapeutics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Ocumension Therapeutics is expected to pay a dividend of 0 CNY.

What is the dividend yield of Ocumension Therapeutics?

The current dividend yield of Ocumension Therapeutics is .

When does Ocumension Therapeutics pay dividends?

Ocumension Therapeutics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Ocumension Therapeutics?

Ocumension Therapeutics paid dividends every year for the past 0 years.

What is the dividend of Ocumension Therapeutics?

For the upcoming 12 months, dividends amounting to 0 CNY are expected. This corresponds to a dividend yield of 0 %.

In which sector is Ocumension Therapeutics located?

Ocumension Therapeutics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Ocumension Therapeutics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Ocumension Therapeutics from 9/13/2024 amounting to 0 CNY, you needed to have the stock in your portfolio before the ex-date on 9/13/2024.

When did Ocumension Therapeutics pay the last dividend?

The last dividend was paid out on 9/13/2024.

What was the dividend of Ocumension Therapeutics in the year 2023?

In the year 2023, Ocumension Therapeutics distributed 0 CNY as dividends.

In which currency does Ocumension Therapeutics pay out the dividend?

The dividends of Ocumension Therapeutics are distributed in CNY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Ocumension Therapeutics

Our stock analysis for Ocumension Therapeutics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Ocumension Therapeutics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.